Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Country / region: Czechia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20121
20131
20151
20163
20171
20191
20221
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Terminated2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Eli Lilly and Company2
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2
Spyre Therapeutics, Inc.2
Amgen1
EA Pharma Co., Ltd.1
Genentech, Inc.1
InDex Pharmaceuticals1
Kyowa Kirin, Inc.1
Odyssey Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases18
Colitis, Ulcerative13
Colitis6
Crohn Disease5
Gastrointestinal Diseases4
Colonic Diseases2
Digestive System Diseases2
Intestinal Diseases2
Abdominal Pain1
Autoimmune Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.